查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000749

放射治療設備市場：按產品類型、放射類型、應用和最終用戶分類 - 全球市場預測 2026-2032

Radiation Therapy Equipment Market by Product Type, Radiation Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，放射治療設備市場價值將達到 75.9 億美元，到 2026 年將成長至 81.4 億美元，到 2032 年將達到 127 億美元，複合年成長率為 7.63%。

主要市場統計數據
基準年 2025 75.9億美元
預計年份：2026年 81.4億美元
預測年份 2032 127億美元
複合年成長率 (%) 7.63%

簡要介紹正在重組放射治療設備採購和部署的臨床、技術和營運協同因素。

在放射治療領域，影像技術、治療計畫演算法和照射平台的進步正推動著技術的不斷改進和臨床應用的整合。醫療機構優先採用能夠提高治療精度、縮短治療時間並與多學科診療路徑整合的設備。隨著醫療服務模式轉向價值導向模式，臨床團隊所需的設備不僅要滿足嚴格的療效和安全性標準，還要能夠簡化工作流程並提升病患體驗。在資金分配更加嚴格和監管力度加大的情況下，策略採購決策越來越重視設備的可維護性、互通性以及在整個生命週期內可證實的臨床效益。

自適應成像、緊湊型放射治療平台、人工智慧驅動的規劃以及服務彈性如何全面重塑臨床路徑和採購重點。

多項變革正在重塑放射治療生態系統，並影響治療的規劃、實施和評估方式。首先，影像引導和自適應放射治療工作流程的成熟，使得高度個人化的治療成為可能，能夠根據治療過程中解剖結構的變化進行調整，從而改變了對設備的要求，並提高了對整合成像功能的需求。其次，緊湊型、成本最佳化的平台的出現，擴大了本地醫療機構的覆蓋範圍，同時也促進了基於資本成本、服務模式和總體擁有成本（TCO）的競爭。

評估近期定價政策對營運的影響，以及供應多元化和在地化服務策略如何減輕採購中斷的影響。

貿易政策調整帶來的新關稅措施，為醫療服務提供者和技術供應商帶來了一系列營運方面的考量。對某些零件和整套放射治療系統徵收進口關稅，可能會增加海外製造設備或依賴國際採購子系統的設備的購買成本。為此，採購團隊正在重新評估總體擁有成本 (TCO) 的運算方法，並更加重視模組化架構，以實現分階段升級、本地維護和零件相容性，從而降低跨境價格波動的影響。

將技術模式、醫療保健服務環境和臨床應用連結起來的關鍵細分見解：優先考慮投資和營運規劃。

了解技術、終端用戶和應用領域的詳細情形，可以為評估產品開發優先順序和部署路徑提供系統性的觀點。從技術角度來看，諸如近距離放射（區分高劑量率和低劑量率方法）、線性加速器（區分高能量和低能配置）、質子治療和立體定位放射治療系統等治療方式，各自展現出獨特的臨床權衡和資本成本特徵。這些技術差異不僅影響臨床適應症的適用性，還影響屏蔽、影像整合和面積等基礎設施要求，最終影響部署計劃和多學科協作需求。

美洲、歐洲、中東和非洲以及亞太地區的區域報銷機制、基礎設施投資和服務網路如何影響設備部署和夥伴關係模式？

區域趨勢正在影響全球部署模式、監管路徑和夥伴關係模式。在美洲，醫保報銷框架、先進癌症中心的集中以及醫院系統整合的趨勢，正在推動對能夠處理複雜適應症的高擴充性、高通量平台的需求。快速回應服務網路和設備故障也是該地區的關鍵考量因素，影響供應商的選擇和售後市場策略。

競爭格局分析，展示了技術整合、服務模式和臨床夥伴關係如何定義供應商差異化和採購標準。

設備供應商之間的競爭動態日益取決於技術差異化、卓越服務以及臨床證據的協作創造。領先的供應商正投資於互通性框架、雲端規劃解決方案和自適應交付能力，以提供超越硬體本身的綜合提案主張。與學術機構和臨床網路的夥伴關係正在加速檢驗研究，並將技術優勢轉化為指南層級的臨床實踐。服務模式也不斷演進，包括基於結果的維護合約和性能保證，將供應商的獎勵與醫療機構的運作和處理能力目標掛鉤。

為醫療保健領導者提供實用建議，以協調採購、培訓和服務策略與臨床目標和營運彈性。

產業領導者應採取多管齊下的策略，使技術投資與臨床目標和財務限制保持一致。首先，優先選擇提供模組化升級路徑和開放互通性的平台，以保護資本投資並簡化與電子健康記錄和影像系統的整合。其次，投資於培訓舉措，以提升物理學家、劑量師和放射線治療的技能，使他們能夠充分利用自動化、自適應計劃和立體定位放射治療功能，從而最大限度地提高治療能力和患者安全。第三，協商服務契約，強調可衡量的正常運轉率保證、可預測的備件供應和本地技術人員認證，以降低生命週期內的不確定性。

為了確保研究結果的可重複性，我們採用了一種透明的混合方法研究途徑，結合了臨床文獻回顧、相關人員訪談和儀器性能分析。

本分析的研究結合了對同行評審的臨床文獻、監管文件、技術白皮書和儀器性能報告的系統性回顧，以及對臨床醫生、醫學物理學家、採購經理和服務經理的定向訪談。研究將定性發現與儀器規格、已發表的臨床試驗結果和已記錄的服務模式進行關聯，從而全面了解儀器的技術能力和操作限制。研究特別關注了近期關於自適應放射治療、立體定位放射治療技術和粒子束治療結果的同行評審證據，以便將儀器的功能置於既定的臨床路徑中進行解讀。

簡潔扼要的結論強調，為了在癌症治療方面取得持續進步，需要平衡臨床創新、生命週期經濟性和服務韌性。

總之，放射治療設備的採購和部署正處於一個轉折點，需要在技術進步、操作實用性和長期可維護性之間取得平衡。影像導引治療、自適應計畫和小型化照射系統的進步為改善臨床療效和病患體驗提供了明確的機會。然而，要實現這些益處，需要採購委員會、臨床團隊和服務機構密切合作，以管理資金、培訓和監管要求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：放射治療設備市場：依產品類型分類

  • 外部照射裝置
    • 直線加速器
    • 立體定位放射治療系統
    • 螺旋斷層放射治療系統
    • 機器人放射外科系統
  • 近距離放射治療裝置（近距離放射治療）

第9章：按放射類型分類的放射治療設備市場

  • 光子束
  • 質子束
  • 電子束
  • 中子束
  • 同位素輻射
  • α粒子/BETA粒子

第10章 放射治療設備市場：依應用領域分類

  • 大腦和神經系統
  • 乳癌
  • 肺
  • 攝護腺
  • 子宮頸癌/婦科癌症
  • 胃腸道癌症

第11章：放射治療設備市場：依最終用戶分類

  • 門診手術中心
  • 癌症研究中心
  • 醫院

第12章：放射治療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：放射治療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：放射治療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國放射治療設備市場

第16章 中國放射治療設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Siemens Healthineers AG
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Ion Beam Applications SA
  • Hitachi, Ltd.
  • RefleXion Medical, Inc.
  • Nordion by Sotera Health LLC
  • Mevion Medical Systems, Inc.
  • Bionix LLC
  • Accuray Incorporated
  • Allengers Medical Systems Ltd
  • BEBIG Medical GmbH
  • BrainLab AG
  • Canon Inc.
  • Carl Zeiss AG
  • China Isotope & Radiation Corporation
  • Eckert and Ziegler AG
  • IntraOp Medical Corp.
  • Klarity Medical & Equipment（GZ）Co., Ltd.
  • Koninklijke Philips NV
  • LINEV Group
  • MinXray, Inc.
  • Mitsubishi Heavy Industries, Ltd.
  • Oraya Therapeutics Inc.
  • PTW Freiburg GmbH
  • Stryker Corporation
  • Sumitomo Heavy Industries, Ltd.
  • Xstrahl Group
Product Code: MRR-02026C4C95C5

The Radiation Therapy Equipment Market was valued at USD 7.59 billion in 2025 and is projected to grow to USD 8.14 billion in 2026, with a CAGR of 7.63%, reaching USD 12.70 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.59 billion
Estimated Year [2026] USD 8.14 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 7.63%

A concise introduction framing the converging clinical, technological, and operational forces reshaping radiation therapy equipment procurement and adoption

The radiation therapy landscape is undergoing a period of concentrated technical refinement and clinical integration, driven by advances in imaging, planning algorithms, and delivery platforms. Providers are prioritizing equipment that improves precision, reduces treatment times, and integrates with multidisciplinary care pathways. As care delivery shifts toward value-based models, clinical teams require devices that not only meet stringent efficacy and safety standards but also enable workflow efficiencies and patient experience improvements. Amidst tighter capital allocation and heightened regulatory scrutiny, strategic procurement decisions increasingly weigh lifecycle serviceability, interoperability, and demonstrable clinical benefit.

Concurrently, research programs and academic centers continue to push modality boundaries, exploring dose escalation strategies, adaptive treatment approaches, and the therapeutic potential of novel particles. This research momentum is complemented by a more informed patient population and referring physicians who expect clear evidence of outcomes and toxicity mitigation. Given these dynamics, executives and clinical leaders must synthesize technological capability with operational readiness and reimbursement realities when evaluating upgrades or new installations. Clear alignment between clinical goals and equipment selection will determine whether institutions maximize clinical outcomes while preserving financial sustainability.

How adaptive imaging, compact delivery platforms, AI-enabled planning, and service resilience are collectively reshaping clinical pathways and procurement priorities

Several transformative shifts are redefining the radiation therapy ecosystem and the way care is planned, delivered, and evaluated. First, the maturation of image-guided and adaptive radiotherapy workflows enables highly personalized treatments that adjust to anatomical changes across a course of care, thus altering equipment requirements and demand for integrated imaging capability. Second, the emergence of compact and cost-optimized platforms expands access to community settings while stimulating competition based on service models and total cost of ownership rather than capital price alone.

Third, computational advances-most notably in treatment planning automation and AI-assisted contouring-are changing workforce skill mixes and highlight the need for vendors to provide software updates and validation frameworks. Fourth, patient-centric design and reduced fractionation regimens are increasing throughput expectations, pushing institutions to balance speed with precision. Lastly, supply chain resilience and aftermarket service strategies have taken on heightened importance as providers prioritize uptime and predictable maintenance costs. Together, these shifts compel stakeholders to re-evaluate clinical pathways, procurement criteria, and vendor partnerships to remain clinically relevant and operationally efficient.

Assessing the operational consequences of recent tariff policies and how supply diversification and local servicing strategies can mitigate procurement disruption

The introduction of new tariff measures originating from trade policy adjustments has introduced a cascade of operational considerations for healthcare providers and technology suppliers. Import duties on select components and finished radiotherapy systems have the potential to raise acquisition costs for equipment that is manufactured abroad or reliant on internationally sourced subsystems. In response, procurement teams are reassessing total cost of ownership calculations and placing greater emphasis on modular architectures that permit phased upgrades, local serviceability, and parts interchangeability to mitigate exposure to cross-border price volatility.

Manufacturers and distributors are adapting by diversifying supplier networks, localizing final assembly where feasible, and renegotiating service contracts to preserve predictable lifecycle economics for customers. Clinical planners and capital committees must therefore anticipate longer lead times for certain configurations and prioritize compatibility with existing infrastructure to avoid costly retrofits. On the positive side, tariffs can accelerate strategies that strengthen domestic manufacturing capabilities and aftermarket ecosystems, creating opportunities for localized maintenance hubs and training programs. Ultimately, the cumulative impact of these trade measures will be felt across procurement timelines, vendor selection frameworks, and long-term maintenance planning, requiring coordinated responses from clinical, financial, and supply chain stakeholders.

Key segmentation insights linking technology modalities, healthcare delivery settings, and clinical applications to prioritize investments and operational planning

Understanding segmentation across technology, end user, and application provides a structured lens to evaluate product development priorities and adoption pathways. When technologies are considered, modalities such as brachytherapy-distinguishing high dose rate and low dose rate approaches-alongside linear accelerators differentiated by high energy and low energy configurations, proton therapy, and stereotactic systems each present distinct clinical trade-offs and capital profiles. These technology distinctions influence not only clinical indication suitability but also infrastructure requirements such as shielding, imaging integration, and room footprint, which in turn affect deployment timelines and multidisciplinary coordination requirements.

From an end user perspective, ambulatory surgical centers-comprising both hospital-affiliated centers and standalone centers-operate under different staffing, reimbursement, and throughput models compared with cancer research centers, which are further categorized into government research institutes and private research institutes, and hospitals, where private hospitals and public hospitals have divergent procurement governance and budget cycles. These differences shape purchase considerations, service level expectations, and training investments. Application segmentation across disease sites such as brain and nervous system treatments, where conventional radiotherapy and stereotactic radiosurgery play distinct roles, breast cancer managed via external beam and intraoperative strategies, lung cancer treated with external beam and stereotactic body radiotherapy, and prostate cancer approached through brachytherapy and external beam modalities, clarifies clinical workflow impacts and device feature priorities. Mapping technologies to end users and applications reveals where integration, clinical evidence generation, and specialized service support are most needed to drive adoption and optimize patient outcomes.

How regional reimbursement, infrastructure investment, and service networks across the Americas, Europe Middle East & Africa, and Asia-Pacific shape equipment adoption and partnership models

Regional dynamics influence adoption patterns, regulatory pathways, and partnership models across the globe. In the Americas, reimbursement frameworks, high concentration of advanced cancer centers, and a trend toward consolidations among hospital systems drive demand for scalable, high-throughput platforms that support complex indications. This region also places a premium on service networks and rapid response for equipment downtime, which shapes vendor selection and aftermarket strategies.

Across Europe, the Middle East & Africa, diverse regulatory landscapes and variable infrastructure investment levels result in a heterogeneous adoption curve where high-income markets prioritize cutting-edge modalities and lower-resource settings focus on cost-effective, durable platforms with strong local service support. Cross-border regulatory harmonization efforts and regional centers of excellence facilitate knowledge transfer and collaborative clinical trials. In the Asia-Pacific region, robust capital investment in cancer care combined with a growing number of privately funded hospitals and research centers propels demand for both advanced modalities and compact systems that can be deployed in tiered healthcare settings. Local manufacturing initiatives and public-private partnerships further influence procurement decisions. These regional patterns underscore the need for flexible commercial strategies that adapt to reimbursement realities, infrastructure constraints, and long-term training commitments.

Competitive landscape analysis showing how technology integration, service models, and clinical partnerships define vendor differentiation and procurement criteria

Competitive dynamics among equipment providers are increasingly defined by a combination of technological differentiation, service excellence, and collaborative clinical evidence generation. Leading vendors invest in interoperability frameworks, cloud-enabled planning solutions, and adaptive delivery capabilities to offer an integrated value proposition that extends beyond the hardware. Partnerships with academic centers and clinical networks accelerate validation studies and help translate technological advantages into guideline-level clinical practice. Service models have evolved to include outcome-based maintenance contracts and performance guarantees that align vendor incentives with institutional uptime and throughput targets.

Smaller and niche suppliers focus on specialized modalities or retrofit solutions that extend the life of installed bases, while larger global corporations emphasize scale, regulatory experience, and expansive service footprints. Strategic acquisitions and alliances continue to be a lever for filling capability gaps, particularly in software, imaging, and particle therapy domains. For purchasers, vendor evaluation now prioritizes lifecycle support, credentialed training programs, and transparent roadmaps for software updates and regulatory compliance. These competitive behaviors create an environment where differentiation is measured by demonstrable clinical impact, predictable service economics, and the ability to integrate into complex hospital IT and imaging ecosystems.

Actionable recommendations for healthcare leaders to align procurement, training, and service strategies with clinical goals and operational resilience

Industry leaders should adopt a multi-pronged strategy to align technological investments with clinical objectives and fiscal constraints. First, prioritize platforms that offer modular upgrade paths and open interoperability to protect capital investments and simplify integration with electronic health records and diagnostic imaging systems. Second, invest in training initiatives that upskill physicists, dosimetrists, and therapists to fully leverage automation, adaptive planning, and stereotactic delivery capabilities, thereby maximizing throughput and patient safety. Third, negotiate service agreements that emphasize measurable uptime commitments, predictable spare parts availability, and local technician certification to reduce lifecycle uncertainty.

Additionally, stakeholders should pursue partnerships with research centers to co-develop protocols and real-world evidence that support new indications and reimbursement discussions. Emphasize pilot programs that validate clinical and operational benefits in situ before large-scale rollouts, and incorporate risk-sharing clauses to align vendor and provider incentives. Finally, maintain active supply chain contingency planning that includes multi-sourcing of critical components and consideration of local assembly or maintenance hubs to minimize exposure to global trade disruptions. By implementing these measures, organizations can enhance clinical outcomes while protecting financial resilience and operational continuity.

A transparent mixed-methods research approach combining clinical literature review, stakeholder interviews, and device performance analysis to ensure reproducible insights

The research underpinning this analysis combined a systematic review of peer-reviewed clinical literature, regulatory filings, technical white papers, and device performance reports with targeted interviews of clinicians, medical physicists, procurement leads, and service managers. Qualitative insights were triangulated with equipment specifications, published clinical trial outcomes, and documented service models to ensure a comprehensive understanding of both technological capabilities and operational constraints. Particular attention was paid to recent peer-reviewed evidence on adaptive radiotherapy, stereotactic techniques, and particle therapy outcomes to contextualize device capabilities within established clinical pathways.

Vendor documentation and installation case studies informed assessments of maintenance strategies and aftermarket support, while regional regulatory guidance and reimbursement policy briefings shaped the interpretation of adoption barriers. Confidential interviews provided real-world perspectives on procurement cycles, training burdens, and downtime tolerance. The methodology emphasized reproducibility and source validation, and where appropriate, findings were cross-checked against multiple independent sources to reduce bias. This mixed-methods approach yields actionable insights that balance clinical nuance with pragmatic operational considerations.

A concise conclusion emphasizing the need to balance clinical innovation, lifecycle economics, and service resilience to achieve sustainable improvements in cancer care

In conclusion, radiation therapy equipment procurement and deployment are at an inflection point where technological sophistication must be balanced with operational pragmatism and long-term serviceability. Advancements in image guidance, adaptive planning, and compact delivery systems present clear opportunities to improve clinical outcomes and patient experience. However, realizing these benefits requires deliberate alignment across procurement committees, clinical teams, and service organizations to manage capital, training, and regulatory demands.

Looking ahead, organizations that adopt modular, interoperable technologies, invest in workforce development, and negotiate robust service arrangements will be better positioned to navigate trade policy shifts and regional variances in reimbursement and infrastructure. Strategic partnerships with research institutions and a focus on generating real-world evidence will further strengthen clinical and commercial propositions. By taking a disciplined approach to technology adoption-one that integrates clinical priorities with lifecycle economics and supply chain resilience-providers can deliver higher-value care while preserving flexibility for future innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Therapy Equipment Market, by Product Type

  • 8.1. External Beam Radiation Therapy Device
    • 8.1.1. Linear Accelerators
    • 8.1.2. Stereotactic Systems
    • 8.1.3. Tomotherapy Systems
    • 8.1.4. Robotic Radiosurgery Systems
  • 8.2. Internal Beam Radiation Therapy Device (Brachytherapy)

9. Radiation Therapy Equipment Market, by Radiation Type

  • 9.1. Photon Beam
  • 9.2. Proton Beam
  • 9.3. Electron Beam
  • 9.4. Neutron Beam
  • 9.5. Isotope-Based Radiation
  • 9.6. Alpha / Beta Particle

10. Radiation Therapy Equipment Market, by Application

  • 10.1. Brain And Nervous System
  • 10.2. Breast
  • 10.3. Lung
  • 10.4. Prostate
  • 10.5. Cervical / Gynecological Cancer
  • 10.6. Gastrointestinal Cancer

11. Radiation Therapy Equipment Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cancer Research Centers
  • 11.3. Hospitals

12. Radiation Therapy Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Radiation Therapy Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Radiation Therapy Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Radiation Therapy Equipment Market

16. China Radiation Therapy Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Siemens Healthineers AG
  • 17.6. Elekta AB
  • 17.7. GE HealthCare Technologies Inc.
  • 17.8. Ion Beam Applications S.A.
  • 17.9. Hitachi, Ltd.
  • 17.10. RefleXion Medical, Inc.
  • 17.11. Nordion by Sotera Health LLC
  • 17.12. Mevion Medical Systems, Inc.
  • 17.13. Bionix LLC
  • 17.14. Accuray Incorporated
  • 17.15. Allengers Medical Systems Ltd
  • 17.16. BEBIG Medical GmbH
  • 17.17. BrainLab AG
  • 17.18. Canon Inc.
  • 17.19. Carl Zeiss AG
  • 17.20. China Isotope & Radiation Corporation
  • 17.21. Eckert and Ziegler AG
  • 17.22. IntraOp Medical Corp.
  • 17.23. Klarity Medical & Equipment (GZ) Co., Ltd.
  • 17.24. Koninklijke Philips N.V.
  • 17.25. LINEV Group
  • 17.26. MinXray, Inc.
  • 17.27. Mitsubishi Heavy Industries, Ltd.
  • 17.28. Oraya Therapeutics Inc.
  • 17.29. PTW Freiburg GmbH
  • 17.30. Stryker Corporation
  • 17.31. Sumitomo Heavy Industries, Ltd.
  • 17.32. Xstrahl Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TOMOTHERAPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TOMOTHERAPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY TOMOTHERAPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ROBOTIC RADIOSURGERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ROBOTIC RADIOSURGERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ROBOTIC RADIOSURGERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PHOTON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PHOTON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PHOTON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROTON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY NEUTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY NEUTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY NEUTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ISOTOPE-BASED RADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ISOTOPE-BASED RADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ISOTOPE-BASED RADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ALPHA / BETA PARTICLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ALPHA / BETA PARTICLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY ALPHA / BETA PARTICLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BRAIN AND NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CERVICAL / GYNECOLOGICAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CERVICAL / GYNECOLOGICAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CERVICAL / GYNECOLOGICAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GASTROINTESTINAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GASTROINTESTINAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)